NCT02224664: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease
- State
- Completed
- Phase
- Phase 1
- People
- 50 taking part
- Started
- Oct 2014
- Primary completion
- Mar 2016
- Arms
- Cohort 3, Cohort 4, Cohort 5, Cohort 6
- Results
- Posted on the registry
- Papers
- doi:10.1007/s40120-018-0114-z
- 25 Aug 2014: Trial registered
- 27 Mar 2017: Trial results posted